AMZN vs PFE: Which Is the Better Buy?
Side-by-side comparison of Amazon.com, Inc. and Pfizer Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-07-04.
Amazon.com, Inc. · Consumer Cyclical
$242.67
+22.0% upside to fair value
Grade B
High Quality
VS
Pfizer Inc. · Healthcare
$25.22
+2.8% upside to fair value
Grade B
QuantHub Verdict
AMZN has more upside to fair value
(+22.0%).
PFE trades at a lower forward P/E
(19.2x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
AMZN |
PFE |
| Current Price |
$242.67 |
$25.22 |
| Fair Value Estimate |
$295.95 |
$25.92 |
| Upside to Fair Value |
+22.0%
|
+2.8%
|
| Market Cap |
$2,610.4B |
$143.7B |
| Forward P/E |
28.7x
|
19.2x
|
| EV / EBITDA |
14.4x
|
12.3x
|
| Price / Sales |
3.5x
|
2.3x
|
| Price / FCF |
-1056.0x
|
15.2x
|
| Revenue Growth YoY |
+16.6%
|
+5.4%
|
| Gross Margin |
50.6%
|
69.3%
|
| Operating Margin |
11.5%
|
23.4%
|
| Return on Equity |
23.3%
|
8.4%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
—
|
6.6%
|
| Analyst Consensus |
Strong Buy
|
Hold
|
Investment Thesis
Amazon.com, Inc. operates a diversified platform with core engines in retail, AWS cloud services, and advertising, leveraging a strong competitive moat driven by scale, logistics, and technology leadership. The company exhibits high business quality with 23.3% ROE, 16.6% revenue growth, and 76.7% earnings growth in the most recent quarter, supported by a widening moat in e-commerce and cloud. Des…
Pfizer Inc. is a leading global biopharmaceutical company with a diversified portfolio dominated by its Biopharma prescription segment, which accounts for over 90% of revenue. The company benefits from a substantial scale, a broad product portfolio including top-selling drugs like Eliquis, Prevnar, and Paxlovid, and a strong manufacturing footprint. However, Pfizer faces challenges from declining…
Accumulation Zones
| Metric |
AMZN |
PFE |
| Zone Low |
$221.96 |
$19.44 |
| Zone High |
$251.56 |
$22.03 |
| In Buy Zone? |
Yes
|
No
|